세계의 장기칩 (Organ-on-chip) 시장 (~2029년) : 간, 신장, 장, 폐, 심장

■ 영문 제목 : Organ-On-Chip Market by Organ Type (Liver, Kidney, Intestine, Lung, Heart), Products (Instruments, Consumable, Software), Services (Standard, Custom), Model Type, Application (Toxicology, Drug Discovery, Stem Cell), Purpose - Global Forecast to 2029

MarketsandMarkets 회사가 출판한 조사자료로, 코드는 BT5883-24 입니다.■ 상품코드 : BT5883-24
■ 조사/발행회사 : MarketsandMarkets
■ 발행일 : 2024년 2월
■ 페이지수 : 338
■ 작성언어 : 영문
■ 보고서 형태 : PDF
■ 납품 방식 : Email (주문후 24시간내 납품)
■ 조사대상 지역 : 글로벌
■ 산업 분야 : 의료
■ 판매가격 / 옵션 (부가세 10% 별도)
Single UserUSD4,950 ⇒환산￦6,930,000견적의뢰/주문/질문
Multi User (Five User)USD6,650 ⇒환산￦9,310,000견적의뢰/주문/질문
Corporate LicenseUSD8,150 ⇒환산￦11,410,000견적의뢰/구입/질문
※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.
"세계의 장기칩 (Organ-on-chip) 시장은 2024년 123,285천 달러에서 2029년 631,073천 달러로 확대될 것으로 예상되며, 예측 기간 동안 연평균 38.6%의 성장률을 기록할 것으로 전망됩니다."장기칩 (Organ-on-chip) 시장의 성장을 촉진하는 주요 요인으로는 동물 모델을 이용한 약물 시험의 대체 방법 개발에 대한 인식 증가, 장기칩 (Organ-on-chip) 시장의 기술 혁신을 위한 정부 기관 및 민간 기관의 자금 지원 증가 등을 꼽을 수 있습니다. 바이오패브리케이션과 미세유체공학 분야의 발전도 이 시장의 성장에 기여하고 있습니다.

장기칩 (Organ-on-chip) 시장은 장기 유형, 모델 유형, 제품 및 서비스, 용도, 목적, 최종 용도에 따라 세분화되어 있습니다.

"모델 유형별로는 장기 기반 모델 세그먼트가 장기칩 (Organ-on-chip) 시장에서 가장 큰 점유율을 차지할 것으로 예상됩니다."
모델 유형별로 장기칩 (Organ-on-chip) 시장은 장기 기반 모델과 질병 기반 모델로 분류되며, 2023년에는 장기 기반 모델이 가장 큰 시장 점유율을 차지할 것으로 예상됩니다. 이는 장기 기반 장기칩 (Organ-on-chip) 모델이 제공하는 높은 정확도와 같은 요인 외에도, 다른 요인들 중에서도 특히 약물 테스트에 동물을 사용하는 것에 대한 윤리적 우려가 높아졌기 때문입니다.

"장기 유형별로는 간 칩 부문이 장기칩 (Organ-on-chip) 시장에서 가장 큰 점유율을 차지했습니다."
장기 유형별로 장기칩 (Organ-on-chip) 시장은 간, 신장, 폐, 심장, 장, 기타 장기로 구분되며, 2023년에는 간 칩 부문이 장기칩 (Organ-on-chip) 시장에서 가장 큰 점유율을 차지할 것으로 예상됩니다. 이 시장 부문의 성장은 약물 대사에서 간의 중요성과 제약 및 생명공학 기업들이 간 칩 모델에서 인간 간세포 독성을 테스트하는 신약 개발에 집중하고 있기 때문입니다.

"북미는 장기칩 (Organ-on-chip) 시장에서 가장 큰 점유율을 차지하는 지역입니다."
장기칩 (Organ-on-chip) 시장에서 가장 큰 점유율을 차지한 지역은 북미 지역입니다. 북미 지역의 높은 점유율은 정부 및 민간 기관의 자금 지원 증가와 동물실험을 대체할 수 있는 기술로 인지도를 높이고 채택을 촉진하기 위한 이니셔티브의 증가에 기인합니다. 또한, 북미 지역은 의료 인프라가 잘 갖추어져 있어 시장 성장을 더욱 촉진하고 있습니다. 또한, 이 지역에는 여러 시장 진입자가 존재한다는 점도 시장 성장을 뒷받침하는 중요한 요인입니다. 예를 들어, Emulate, Inc. (US), Obatala Sciences (US), SynVivo, Inc. (US), Nortis, Inc. (US) Axosim (US) 등이 있습니다.

"유럽은 장기칩 (Organ-on-chip) 시장에서 두 번째로 큰 지역입니다."
유럽은 장기칩 (Organ-on-chip) 시장은 장기칩 (Organ-on-chip) 시장에서 두 번째로 큰 시장입니다. 이는 장기칩 (Organ-on-chip) 기술 발전을 위한 이니셔티브의 증가, 약물 개발 및 검사를 위한 인공지능과 같은 첨단 기술의 사용 증가 등의 주요 요인 중 하나에 기인합니다. 또한 정부 기관과 민간 기관의 협력과 지원도 이 시장의 성장을 촉진하고 있습니다.

본 보고서를 위해 실시한 1차 인터뷰는 다음과 같이 분류할 수 있습니다.
- 응답자별 : 공급측 70%, 수요측 30%.
- 직급별 : 관리자 : 45%, 임원 : 30%, 경영진 : 25%.
- 국가별 : 북미 40%, 유럽 30%, 아시아 태평양 20%, 중남미 5%, 중동 및 아프리카 5%.

주요 플레이어
• Emulate, Inc. (US)
• MIMETAS B.V. (Netherlands)
• TissUse GmBH (Germany)
• Insphero (Switzerland)
• CN Bio Innovations Ltd (UK)
• Dynamic42 GmBH (Germany)
• React4Life (Italy)
• Biomimx S.R.L (Italy)
• Netri (France)
• SynVivo, Inc. (US)
• Nortis, Inc. (US)
• Axosim (US)
• Obatala Sciences (US)
• AlveoliX AG (Switzerland)
• Beonchip (Spain)
• Initio Cell (Netherlands)
• Netri SAS (France)
• Hesperos, Inc. (US)
• Lena Biosciences (US)
• RevivoCell (UK)
• Altis Biosystems (US)
• Bi/ond (Netherlands)
• Cherry Biotech (France)
• Fluigent (France)
• Elvesys (France)

조사 범위
본 조사 보고서는 장기칩 (Organ-on-chip) 시장의 상세한 현황을 수록하고 있습니다. 장기 종류, 모델 유형, 제품 및 서비스, 용도, 목적, 최종 용도, 지역(북미, 유럽, 아시아 태평양, 중남미, 중동, 아프리카) 등 다양한 부문에 걸친 시장 규모와 향후 성장 가능성을 추정하는 것을 목적으로 합니다. 또한 주요 시장 플레이어의 회사 개요, 최근 동향 및 주요 시장 전략과 함께 상세한 경쟁 분석이 포함되어 있습니다.

보고서 구매의 주요 이점
이 보고서는 장기칩 (Organ-on-chip) 시장 및 해당 부문의 수익 수치에 가장 근접한 추정치를 제공함으로써 시장 리더/신규 진입자에게 도움을 줍니다. 또한 이해관계자들이 경쟁 현황을 더 잘 이해하고, 비즈니스를 더 잘 포지셔닝하고, 적절한 시장 진입 전략을 수립할 수 있는 통찰력을 얻을 수 있도록 도와줍니다. 이 보고서는 이해관계자들이 시장의 흐름을 이해하고 주요 시장 촉진 요인, 저해 요인, 동향, 기회 및 도전 과제에 대한 정보를 제공할 수 있도록 합니다.

이 보고서는 다음 사항에 대한 통찰력을 제공합니다.
- 장기칩 (Organ-on-chip) 시장의 성장에 영향을 미치는 주요 촉진 요인(대체 약물 검사법 개발), 기회(다중 장기칩 (Organ-on-chip) 개발 및 화장품 및 식품 산업으로의 적용 확대), 억제 요인(전임상 단계에서의 제한적인 기술 사용), 도전 과제(낮은 처리량 및 확장성)를 분석합니다.
- 제품 개발/혁신 : 장기칩 (Organ-on-chip) 시장의 향후 기술, 연구개발 활동, 신제품 출시에 대한 심층적인 통찰력을 제공합니다.
- 시장 개발 : 유리한 시장에 대한 포괄적인 정보 - 이 보고서는 다양한 지역의 장기칩 (Organ-on-chip) 시장을 분석합니다.
- 시장 다각화 : 장기칩 (Organ-on-chip) 시장의 신제품 및 서비스, 미개척 지역, 최근 개발 및 투자에 대한 자세한 정보를 제공합니다.
- 경쟁 평가 : 주요 기업의 시장 점유율, 성장 전략, 제품 및 서비스 내용을 상세히 평가합니다.
■ 보고서 개요

1 서론
2 조사 방법
4 프리미엄 인사이트
5 시장 개요
6 세계의 장기칩 (Organ-on-chip) 시장 규모 : 장기 유형별
7 세계의 장기칩 (Organ-on-chip) 시장 규모 : 모델 유형별
8 세계의 장기칩 (Organ-on-chip) 시장 규모 : 제품 및 서비스별
9 세계의 장기칩 (Organ-on-chip) 시장 규모 : 용도별
10 세계의 장기칩 (Organ-on-chip) 시장 규모 : 목적별
11 세계의 장기칩 (Organ-on-chip) 시장 규모 : 최종 용도별
12 세계의 장기칩 (Organ-on-chip) 시장 규모 : 지역별
13 경쟁 현황
14 기업 정보
15 부록

■ 보고서 목차

1 INTRODUCTION 46
1.1 STUDY OBJECTIVES 46
1.2 MARKET DEFINITION 47
1.3 INCLUSIONS & EXCLUSIONS 47
1.4 MARKET SCOPE 48
FIGURE 1 ORGANS-ON-CHIPS MARKET SEGMENTATION 48
FIGURE 2 REGIONAL SEGMENTATION 48
1.4.1 YEARS CONSIDERED 49
1.4.2 CURRENCY CONSIDERED 49
1.5 RESEARCH LIMITATIONS 49
1.6 STAKEHOLDERS 50
1.7 SUMMARY OF CHANGES 50
1.7.1 RECESSION IMPACT 50
2 RESEARCH METHODOLOGY 52
2.1 RESEARCH DATA 52
FIGURE 3 RESEARCH DESIGN 52
2.1.1 SECONDARY DATA 53
2.1.2 PRIMARY DATA 53
FIGURE 4 BREAKDOWN OF PRIMARIES: SUPPLY- AND DEMAND-SIDE PARTICIPANTS 54
2.2 MARKET SIZE ESTIMATION 55
FIGURE 5 MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS, 2023 55
FIGURE 6 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2023 56
FIGURE 7 MARKET VALIDATION FROM PRIMARY EXPERTS 57
2.2.1 MARKET SIZE ASSESSMENT AT SEGMENTAL LEVEL 57
FIGURE 8 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 57
2.3 MARKET GROWTH FORECAST 58
FIGURE 9 CAGR PROJECTIONS: ORGANS-ON-CHIPS MARKET, 2024–2029 59
FIGURE 10 GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN ORGANS-ON-CHIPS MARKET 60
2.4 MARKET BREAKDOWN & DATA TRIANGULATION 60
FIGURE 11 DATA TRIANGULATION METHODOLOGY 61
2.5 STUDY ASSUMPTIONS 61
2.6 RISK ANALYSIS 62
2.7 RECESSION IMPACT ANALYSIS 62
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2028 (% GROWTH) 62
TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION) 63
TABLE 3 US HEALTH EXPENDITURE, 2023–2030 (USD MILLION) 63
3 EXECUTIVE SUMMARY 64
FIGURE 12 ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2024 VS. 2029 (USD THOUSAND) 64
FIGURE 13 ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2024 VS. 2029 (USD THOUSAND) 65
FIGURE 14 ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2024 VS. 2029 (USD THOUSAND) 66
FIGURE 15 ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2024 VS. 2029 (USD THOUSAND) 66
FIGURE 16 ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2024 VS. 2029 (USD THOUSAND) 67
FIGURE 17 ORGANS-ON-CHIPS MARKET, BY END USER, 2024 VS. 2029 (USD THOUSAND) 68
FIGURE 18 GEOGRAPHICAL SNAPSHOT: ORGANS-ON-CHIPS MARKET 69
4 PREMIUM INSIGHTS 70
4.1 ORGANS-ON-CHIPS MARKET OVERVIEW 70
FIGURE 19 RISING ADOPTION OF ORGANS-ON-CHIPS BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DRIVE MARKET 70
4.2 NORTH AMERICA: ORGANS-ON-CHIPS MARKET SHARE, BY MODEL TYPE & COUNTRY (2023) 71
FIGURE 20 ORGAN-BASED MODELS TO DOMINATE NORTH AMERICAN ORGANS-ON-CHIPS MARKET IN 2023 71
4.3 ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2024 VS. 2029 (USD THOUSAND) 71
FIGURE 21 TOXICOLOGY RESEARCH TO DOMINATE MARKET BY 2029 71
4.4 ORGANS-ON-CHIPS MARKET SHARE, BY END USER, 2023 72
FIGURE 22 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES ACCOUNTED FOR LARGEST MARKET SHARE IN 2023 72
4.5 ORGANS-ON-CHIPS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 72
FIGURE 23 GERMANY TO REGISTER HIGHEST GROWTH RATE IN ORGANS-ON-CHIPS MARKET FROM 2024 TO 2029 72
5 MARKET OVERVIEW 73
5.1 INTRODUCTION 73
5.2 MARKET DYNAMICS 74
FIGURE 24 ORGANS-ON-CHIPS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 74
TABLE 4 ORGANS-ON-CHIPS MARKET: IMPACT ANALYSIS 75
5.2.1 DRIVERS 76
5.2.1.1 Increasing demand for animal-free testing 76
5.2.1.2 Ethical concerns regarding use of animal models in drug development 76
5.2.1.3 Growing drug discovery & development initiatives 77
5.2.1.4 Development of personalized medicines 77
5.2.1.5 Advancements in microfluidics and bioengineering 78
5.2.1.6 Increased government and private funding 78
5.2.1.7 Greater adoption of OOC technology by pharma & biotech companies 79
5.2.2 RESTRAINTS 80
5.2.2.1 Limitation of use restricted to preclinical trials 80
5.2.2.2 Limited scalability and throughput 80
5.2.3 OPPORTUNITIES 81
5.2.3.1 Development of human-on-a-chip models 81
5.2.3.2 Increasing applications in diverse industries 81
5.2.3.3 Developing hybrid business model providing both products and services 82
5.2.4 CHALLENGES 82
5.2.4.1 Lack of standardization 82
5.2.4.2 Mimicking complex tissues and organs 83
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 83
FIGURE 25 REVENUE SHIFT & NEW POCKETS FOR PRODUCT & SERVICE PROVIDERS 83
5.4 PRICING ANALYSIS 84
TABLE 5 AVERAGE SELLING PRICE FOR KEY PLAYERS, BY PRODUCT 84
5.5 VALUE CHAIN ANALYSIS 85
FIGURE 26 VALUE CHAIN ANALYSIS: RESEARCH & DEVELOPMENT PHASE ADDS MAXIMUM VALUE 85
5.6 ECOSYSTEM ANALYSIS 86
FIGURE 27 ECOSYSTEM ANALYSIS: ORGANS-ON-CHIPS MARKET 86
5.7 PATENT ANALYSIS 87
FIGURE 28 PATENT APPLICATIONS FOR ORGAN-ON-A-CHIP PRODUCTS, JANUARY 2012–DECEMBER 2023 87
TABLE 6 ORGANS-ON-CHIPS MARKET: INDICATIVE LIST OF PATENTS 87
5.8 SUPPLY CHAIN ANALYSIS 88
FIGURE 29 ORGANS-ON-CHIPS MARKET: SUPPLY CHAIN ANALYSIS 89
TABLE 7 OVERALL SUPPLY CHAIN ECOSYSTEM FOR ORGANS-ON-CHIPS MARKET 89
5.9 TECHNOLOGY ANALYSIS 90
5.10 CASE STUDY ANALYSIS 91
5.10.1 QUEEN MARY UNIVERSITY LONDON (QMUL) COLLABORATED WITH EMULATE TO ESTABLISH QUEEN MARY+EMULATE ORGANS-ON-CHIPS CENTRE 91
5.11 TRADE ANALYSIS 91
5.12 KEY CONFERENCES & EVENTS IN 2024 91
TABLE 8 ORGANS-ON-CHIPS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 91
5.13 REGULATORY ANALYSIS 93
5.13.1 REGULATORY ANALYSIS 93
5.13.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 93
TABLE 9 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 93
TABLE 10 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 94
TABLE 11 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 95
TABLE 12 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 95
5.14 PORTER’S FIVE FORCES ANALYSIS 96
TABLE 13 ORGANS-ON-CHIPS MARKET: PORTER’S FIVE FORCES ANALYSIS 96
5.14.1 THREAT OF NEW ENTRANTS 96
5.14.2 THREAT OF SUBSTITUTES 96
5.14.3 BARGAINING POWER OF BUYERS 97
5.14.4 BARGAINING POWER OF SUPPLIERS 97
5.14.5 DEGREE OF COMPETITION 97
5.15 KEY STAKEHOLDERS & BUYING CRITERIA 98
5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS 98
FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF PRODUCTS 98
FIGURE 31 KEY BUYING CRITERIA FOR END USERS 98
6 ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE 99
6.1 INTRODUCTION 100
TABLE 14 ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND) 100
6.2 LIVER 100
6.2.1 INCREASING PRECLINICAL RESEARCH TO EVALUATE HEPATOTOXICITY TO AID MARKET GROWTH 100
TABLE 15 LIVER-ON-A-CHIP MARKET, BY REGION, 2022–2029 (USD THOUSAND) 101
TABLE 16 NORTH AMERICA: LIVER-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 101
TABLE 17 EUROPE: LIVER-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 102
TABLE 18 ASIA PACIFIC: LIVER-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 102
TABLE 19 LATIN AMERICA: LIVER-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 103
6.3 KIDNEY 103
6.3.1 USE OF KIDNEY-ON-A-CHIP MODELS FOR DIKI ASSESSMENT TO SUPPORT MARKET GROWTH 103
TABLE 20 KIDNEY-ON-A-CHIP MARKET, BY REGION, 2022–2029 (USD THOUSAND) 104
TABLE 21 NORTH AMERICA: KIDNEY-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 104
TABLE 22 EUROPE: KIDNEY-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 105
TABLE 23 ASIA PACIFIC: KIDNEY-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 105
TABLE 24 LATIN AMERICA: KIDNEY-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 106
6.4 INTESTINE 106
6.4.1 INCREASING RESEARCH ON GASTROINTESTINAL DISEASE TO PROMOTE GROWTH 106
TABLE 25 INTESTINE-ON-A-CHIP MARKET, BY REGION, 2022–2029 (USD THOUSAND) 107
TABLE 26 NORTH AMERICA: INTESTINE-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 107
TABLE 27 EUROPE: INTESTINE-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 108
TABLE 28 ASIA PACIFIC: INTESTINE-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 108
TABLE 29 LATIN AMERICA: INTESTINE-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 109
6.5 LUNG 109
6.5.1 ENHANCED PARTICLE SCREENING FOR EVALUATING PULMONARY TOXICITY TO SUPPORT ADOPTION 109
TABLE 30 LUNG-ON-A-CHIP MARKET, BY REGION, 2022–2029 (USD THOUSAND) 110
TABLE 31 NORTH AMERICA: LUNG-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 110
TABLE 32 EUROPE: LUNG-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 111
TABLE 33 ASIA PACIFIC: LUNG-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 111
TABLE 34 LATIN AMERICA: LUNG-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 112
6.6 HEART 112
6.6.1 INCREASING ADOPTION IN STUDYING CARDIOVASCULAR DISEASES TO DRIVE MARKET 112
TABLE 35 HEART-ON-A-CHIP MARKET, BY REGION, 2022–2029 (USD THOUSAND) 113
TABLE 36 NORTH AMERICA: HEART-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 113
TABLE 37 EUROPE: HEART-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 114
TABLE 38 ASIA PACIFIC: HEART-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 114
TABLE 39 LATIN AMERICA: HEART-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 115
6.7 OTHER ORGANS 115
TABLE 40 OTHER ORGANS-ON-CHIPS MARKET, BY REGION, 2022–2029 (USD THOUSAND) 115
TABLE 41 NORTH AMERICA: OTHER ORGANS-ON-CHIPS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 115
TABLE 42 EUROPE: OTHER ORGANS-ON-CHIPS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 116
TABLE 43 ASIA PACIFIC: OTHER ORGANS-ON-CHIPS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 117
TABLE 44 LATIN AMERICA: OTHER ORGANS-ON-CHIPS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 117
7 ORGANS-ON-CHIPS MARKET, BY MODEL TYPE 118
7.1 INTRODUCTION 119
TABLE 45 ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND) 119
7.2 ORGAN-BASED MODELS 119
7.2.1 INCREASING RESEARCH TO UNDERSTAND ORGAN PHYSIOLOGY TO SUPPORT MARKET GROWTH 119
TABLE 46 ORGANS-ON-CHIPS MARKET FOR ORGAN-BASED MODELS, BY REGION, 2022–2029 (USD THOUSAND) 120
TABLE 47 NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR ORGAN-BASED MODELS, BY COUNTRY, 2022–2029 (USD THOUSAND) 120
TABLE 48 EUROPE: ORGANS-ON-CHIPS MARKET FOR ORGAN-BASED MODELS, BY COUNTRY, 2022–2029 (USD THOUSAND) 121
TABLE 49 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR ORGAN-BASED MODELS, BY COUNTRY, 2022–2029 (USD THOUSAND) 121
TABLE 50 LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR ORGAN-BASED MODELS, BY COUNTRY, 2022–2029 (USD THOUSAND) 122
7.3 DISEASE-BASED MODELS 122
7.3.1 GROWING USE OF OOC PLATFORMS FOR DRUG DISCOVERY & DEVELOPMENT TO SUPPORT MARKET GROWTH 122
TABLE 51 ORGANS-ON-CHIPS MARKET FOR DISEASE-BASED MODELS, BY REGION, 2022–2029 (USD THOUSAND) 123
TABLE 52 NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR DISEASE-BASED MODELS, BY COUNTRY, 2022–2029 (USD THOUSAND) 123
TABLE 53 EUROPE: ORGANS-ON-CHIPS MARKET FOR DISEASE-BASED MODELS, BY COUNTRY, 2022–2029 (USD THOUSAND) 124
TABLE 54 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR DISEASE-BASED MODELS, BY COUNTRY, 2022–2029 (USD THOUSAND) 124
TABLE 55 LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR DISEASE-BASED MODELS, BY COUNTRY, 2022–2029 (USD THOUSAND) 125
8 ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE 126
8.1 INTRODUCTION 127
TABLE 56 ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND) 127
8.2 SERVICES 127
TABLE 57 ORGAN-ON-A-CHIP SERVICES MARKET, BY REGION, 2022–2029 (USD THOUSAND) 127
TABLE 58 NORTH AMERICA: ORGAN-ON-A-CHIP SERVICES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 128
TABLE 59 EUROPE: ORGAN-ON-A-CHIP SERVICES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 128
TABLE 60 ASIA PACIFIC: ORGAN-ON-A-CHIP SERVICES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 129
TABLE 61 LATIN AMERICA: ORGAN-ON-A-CHIP SERVICES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 129
TABLE 62 ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 130
8.2.1 CUSTOM SERVICES 130
8.2.1.1 Growing demand for customized platforms for therapeutics and research to aid growth 130
TABLE 63 CUSTOM SERVICES MARKET, BY REGION, 2022–2029 (USD THOUSAND) 130
TABLE 64 NORTH AMERICA: CUSTOM SERVICES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 131
TABLE 65 EUROPE: CUSTOM SERVICES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 131
TABLE 66 ASIA PACIFIC: CUSTOM SERVICES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 132
TABLE 67 LATIN AMERICA: CUSTOM SERVICES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 132
8.2.2 STANDARD SERVICES 132
8.2.2.1 Increasing use of pre-seeded platforms for drug toxicity assessments to support growth 132
TABLE 68 STANDARD SERVICES MARKET, BY REGION, 2022–2029 (USD THOUSAND) 133
TABLE 69 NORTH AMERICA: STANDARD SERVICES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 133
TABLE 70 EUROPE: STANDARD SERVICES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 134
TABLE 71 ASIA PACIFIC: STANDARD SERVICES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 134
TABLE 72 LATIN AMERICA: STANDARD SERVICES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 135
8.3 PRODUCTS 135
TABLE 73 ORGAN-ON-A-CHIP PRODUCTS MARKET, BY REGION, 2022–2029 (USD THOUSAND) 135
TABLE 74 NORTH AMERICA: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 136
TABLE 75 EUROPE: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 136
TABLE 76 ASIA PACIFIC: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 137
TABLE 77 LATIN AMERICA: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 137
TABLE 78 ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 138
8.3.1 INSTRUMENTS 138
8.3.1.1 Increasing adoption of platforms for drug discovery and development to support market growth 138
TABLE 79 INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD THOUSAND) 139
TABLE 80 NORTH AMERICA: INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 139
TABLE 81 EUROPE: INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 140
TABLE 82 ASIA PACIFIC: INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 140
TABLE 83 LATIN AMERICA: INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 141
8.3.2 CONSUMABLES & ACCESSORIES 141
8.3.2.1 Growing emphasis on using OOC models for research to drive market 141
TABLE 84 CONSUMABLES & ACCESSORIES MARKET, BY REGION, 2022–2029 (USD THOUSAND) 142
TABLE 85 NORTH AMERICA: CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 142
TABLE 86 EUROPE: CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 143
TABLE 87 ASIA PACIFIC: CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 143
TABLE 88 LATIN AMERICA: CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 144
8.3.3 SOFTWARE 144
8.3.3.1 Increasing integration of AI for data analytics and prediction to support market growth 144
TABLE 89 SOFTWARE MARKET, BY REGION, 2022–2029 (USD THOUSAND) 144
TABLE 90 NORTH AMERICA: SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 145
TABLE 91 EUROPE: SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 145
TABLE 92 ASIA PACIFIC: SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 145
TABLE 93 LATIN AMERICA: SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 146
9 ORGANS-ON-CHIPS MARKET, BY APPLICATION 147
9.1 INTRODUCTION 148
TABLE 94 ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND) 148
9.2 TOXICOLOGY RESEARCH 148
9.2.1 EFFECTIVE OUTCOMES TO SUPPORT GROWTH 148
TABLE 95 ORGANS-ON-CHIPS MARKET FOR TOXICOLOGY RESEARCH, BY REGION, 2022–2029 (USD THOUSAND) 149
TABLE 96 NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR TOXICOLOGY RESEARCH, BY COUNTRY, 2022–2029 (USD THOUSAND) 149
TABLE 97 EUROPE: ORGANS-ON-CHIPS MARKET FOR TOXICOLOGY RESEARCH, BY COUNTRY, 2022–2029 (USD THOUSAND) 150
TABLE 98 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR TOXICOLOGY RESEARCH, BY COUNTRY, 2022–2029 (USD THOUSAND) 150
TABLE 99 LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR TOXICOLOGY RESEARCH, BY COUNTRY, 2022–2029 (USD THOUSAND) 151
9.3 DRUG DISCOVERY 151
9.3.1 INCREASING FOCUS OF PHARMA COMPANIES ON ADOPTING OOC TO SUPPORT GROWTH 151
TABLE 100 ORGANS-ON-CHIPS MARKET FOR DRUG DISCOVERY, BY REGION, 2022–2029 (USD THOUSAND) 152
TABLE 101 NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2022–2029 (USD THOUSAND) 152
TABLE 102 EUROPE: ORGANS-ON-CHIPS MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2022–2029 (USD THOUSAND) 153
TABLE 103 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2022–2029 (USD THOUSAND) 153
TABLE 104 LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2022–2029 (USD THOUSAND) 154
9.4 PHYSIOLOGICAL MODEL DEVELOPMENT 154
9.4.1 ACCURACY IN STUDYING IN VIVO MECHANISMS TO DRIVE MARKET 154
TABLE 105 ORGANS-ON-CHIPS MARKET FOR PHYSIOLOGICAL MODEL DEVELOPMENT, BY REGION, 2022–2029 (USD THOUSAND) 155
TABLE 106 NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR PHYSIOLOGICAL MODEL DEVELOPMENT, BY COUNTRY, 2022–2029 (USD THOUSAND) 155
TABLE 107 EUROPE: ORGANS-ON-CHIPS MARKET FOR PHYSIOLOGICAL MODEL DEVELOPMENT, BY COUNTRY, 2022–2029 (USD THOUSAND) 156
TABLE 108 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR PHYSIOLOGICAL MODEL DEVELOPMENT, BY COUNTRY, 2022–2029 (USD THOUSAND) 156
TABLE 109 LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR PHYSIOLOGICAL MODEL DEVELOPMENT, BY COUNTRY, 2022–2029 (USD THOUSAND) 157
9.5 TISSUE REGENERATION & REGENERATIVE MEDICINE 157
9.5.1 GROWING RESEARCH INITIATIVES TO SUPPORT MARKET GROWTH 157
TABLE 110 ORGANS-ON-CHIPS MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE, BY REGION, 2022–2029 (USD THOUSAND) 158
TABLE 111 NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD THOUSAND) 158
TABLE 112 EUROPE: ORGANS-ON-CHIPS MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD THOUSAND) 159
TABLE 113 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD THOUSAND) 159
TABLE 114 LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD THOUSAND) 160
9.6 STEM CELL RESEARCH 160
9.6.1 GROWING FOCUS ON STEM CELL RESEARCH TO SUPPORT GROWTH 160
TABLE 115 ORGANS-ON-CHIPS MARKET FOR STEM CELL RESEARCH, BY REGION, 2022–2029 (USD THOUSAND) 160
TABLE 116 NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022–2029 (USD THOUSAND) 161
TABLE 117 EUROPE: ORGANS-ON-CHIPS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022–2029 (USD THOUSAND) 161
TABLE 118 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022–2029 (USD THOUSAND) 162
TABLE 119 LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022–2029 (USD THOUSAND) 162
10 ORGANS-ON-CHIPS MARKET, BY PURPOSE 163
10.1 INTRODUCTION 164
TABLE 120 ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND) 164
10.2 THERAPEUTICS 164
10.2.1 INCREASING USE OF OOC TECHNOLOGY IN PRECISION MEDICINE AND TARGETED THERAPY RESEARCH TO AID GROWTH 164
TABLE 121 ORGANS-ON-CHIPS MARKET FOR THERAPEUTICS, BY REGION, 2022–2029 (USD THOUSAND) 165
TABLE 122 NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR THERAPEUTICS, BY COUNTRY, 2022–2029 (USD THOUSAND) 165
TABLE 123 EUROPE: ORGANS-ON-CHIPS MARKET FOR THERAPEUTICS, BY COUNTRY, 2022–2029 (USD THOUSAND) 166
TABLE 124 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR THERAPEUTICS, BY COUNTRY, 2022–2029 (USD THOUSAND) 166
TABLE 125 LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR THERAPEUTICS, BY COUNTRY, 2022–2029 (USD THOUSAND) 167
10.3 RESEARCH 167
10.3.1 INCREASING USE OF OOC PLATFORM FOR RESEARCH TO SUPPORT MARKET GROWTH 167
TABLE 126 ORGANS-ON-CHIPS MARKET FOR RESEARCH, BY REGION, 2022–2029 (USD THOUSAND) 168
TABLE 127 NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR RESEARCH, BY COUNTRY, 2022–2029 (USD THOUSAND) 168
TABLE 128 EUROPE: ORGANS-ON-CHIPS MARKET FOR RESEARCH, BY COUNTRY, 2022–2029 (USD THOUSAND) 169
TABLE 129 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR RESEARCH, BY COUNTRY, 2022–2029 (USD THOUSAND) 169
TABLE 130 LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR RESEARCH, BY COUNTRY, 2022–2029 (USD THOUSAND) 170
11 ORGANS-ON-CHIPS MARKET, BY END USER 171
11.1 INTRODUCTION 172
TABLE 131 ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND) 172
11.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 172
11.2.1 INCREASING COLLABORATION BETWEEN PHARMACEUTICAL COMPANIES AND OOC MANUFACTURERS TO DRIVE MARKET 172
TABLE 132 ORGANS-ON-CHIPS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD THOUSAND) 173
TABLE 133 NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD THOUSAND) 173
TABLE 134 EUROPE: ORGANS-ON-CHIPS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD THOUSAND) 174
TABLE 135 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD THOUSAND) 174
TABLE 136 LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD THOUSAND) 175
11.3 COSMETICS INDUSTRY 175
11.3.1 GROWING EMPHASIS ON ANIMAL-FREE DRUG TESTING TO PROMOTE MARKET GROWTH 175
TABLE 137 ORGANS-ON-CHIPS MARKET FOR COSMETICS INDUSTRY, BY REGION, 2022–2029 (USD THOUSAND) 176
TABLE 138 NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2022–2029 (USD THOUSAND) 176
TABLE 139 EUROPE: ORGANS-ON-CHIPS MARKET FOR COSMETICS INDUSTRY, 2022–2029 (USD THOUSAND) 177
TABLE 140 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2022–2029 (USD THOUSAND) 177
TABLE 141 LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2022–2029 (USD THOUSAND) 178
11.4 ACADEMIC & RESEARCH INSTITUTES 178
11.4.1 INCREASING RESEARCH INTO APPLICATIONS OF OOC TECHNOLOGY TO SUPPORT MARKET GROWTH 178
TABLE 142 ORGANS-ON-CHIPS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD THOUSAND) 179
TABLE 143 NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD THOUSAND) 179
TABLE 144 EUROPE: ORGANS-ON-CHIPS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD THOUSAND) 180
TABLE 145 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD THOUSAND) 180
TABLE 146 LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD THOUSAND) 181
11.5 OTHER END USERS 181
TABLE 147 ORGANS-ON-CHIPS MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD THOUSAND) 182
TABLE 148 NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD THOUSAND) 182
TABLE 149 EUROPE: ORGANS-ON-CHIPS MARKET FOR OTHER END USERS, 2022–2029 (USD THOUSAND) 183
TABLE 150 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD THOUSAND) 183
TABLE 151 LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD THOUSAND) 184
12 ORGANS-ON-CHIPS MARKET, BY REGION 185
12.1 INTRODUCTION 186
TABLE 152 ORGANS-ON-CHIPS MARKET, BY REGION, 2022–2029 (USD THOUSAND) 186
12.2 NORTH AMERICA 186
FIGURE 32 NORTH AMERICA: ORGANS-ON-CHIPS MARKET SNAPSHOT 187
TABLE 153 NORTH AMERICA: ORGANS-ON-CHIPS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 188
TABLE 154 NORTH AMERICA: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND) 188
TABLE 155 NORTH AMERICA: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND) 189
TABLE 156 NORTH AMERICA: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND) 189
TABLE 157 NORTH AMERICA: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 189
TABLE 158 NORTH AMERICA: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 190
TABLE 159 NORTH AMERICA: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND) 190
TABLE 160 NORTH AMERICA: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND) 191
TABLE 161 NORTH AMERICA: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND) 191
12.2.1 US 191
12.2.1.1 US to dominate market due to presence of major companies 191
TABLE 162 US: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND) 192
TABLE 163 US: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND) 192
TABLE 164 US: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND) 193
TABLE 165 US: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 193
TABLE 166 US: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 193
TABLE 167 US: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND) 194
TABLE 168 US: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND) 194
TABLE 169 US: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND) 195
12.2.2 CANADA 195
12.2.2.1 Favorable regulatory environment to support market growth 195
TABLE 170 CANADA: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND) 196
TABLE 171 CANADA: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND) 196
TABLE 172 CANADA: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND) 196
TABLE 173 CANADA: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 197
TABLE 174 CANADA: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 197
TABLE 175 CANADA: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND) 197
TABLE 176 CANADA: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND) 198
TABLE 177 CANADA: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND) 198
12.2.3 NORTH AMERICA: RECESSION IMPACT 198
12.3 EUROPE 199
FIGURE 33 EUROPE: ORGANS-ON-CHIPS MARKET SNAPSHOT 200
TABLE 178 EUROPE: ORGANS-ON-CHIPS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND) 201
TABLE 179 EUROPE: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND) 201
TABLE 180 EUROPE: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND) 202
TABLE 181 EUROPE: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND) 202
TABLE 182 EUROPE: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 202
TABLE 183 EUROPE: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 203
TABLE 184 EUROPE: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND) 203
TABLE 185 EUROPE: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND) 204
TABLE 186 EUROPE: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND) 204
12.3.1 GERMANY 204
12.3.1.1 Favorable government policies to propel market 204
TABLE 187 GERMANY: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND) 205
TABLE 188 GERMANY: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND) 205
TABLE 189 GERMANY: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND) 206
TABLE 190 GERMANY: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 206
TABLE 191 GERMANY: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 206
TABLE 192 GERMANY: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND) 207
TABLE 193 GERMANY: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND) 207
TABLE 194 GERMANY: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND) 208
12.3.2 UK 208
12.3.2.1 Growing R&D expenditure in pharmaceutical industry to boost market 208
TABLE 195 UK: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND) 209
TABLE 196 UK: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND) 209
TABLE 197 UK: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND) 209
TABLE 198 UK: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 210
TABLE 199 UK: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 210
TABLE 200 UK: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND) 210
TABLE 201 UK: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND) 211
TABLE 202 UK: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND) 211
12.3.3 FRANCE 211
12.3.3.1 Growing funding for research projects to drive market 211
TABLE 203 FRANCE: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND) 212
TABLE 204 FRANCE: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND) 212
TABLE 205 FRANCE: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND) 213
TABLE 206 FRANCE: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 213
TABLE 207 FRANCE: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 213
TABLE 208 FRANCE: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND) 214
TABLE 209 FRANCE: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND) 214
TABLE 210 FRANCE: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND) 215
12.3.4 ITALY 215
12.3.4.1 Growing research to aid growth 215
TABLE 211 ITALY: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND) 215
TABLE 212 ITALY: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND) 216
TABLE 213 ITALY: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND) 216
TABLE 214 ITALY: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 216
TABLE 215 ITALY: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 217
TABLE 216 ITALY: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND) 217
TABLE 217 ITALY: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND) 217
TABLE 218 ITALY: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND) 218
12.3.5 SPAIN 218
12.3.5.1 Growing R&D expenditure to boost market 218
TABLE 219 SPAIN: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND) 218
TABLE 220 SPAIN: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND) 219
TABLE 221 SPAIN: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND) 219
TABLE 222 SPAIN: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 219
TABLE 223 SPAIN: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 220
TABLE 224 SPAIN: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND) 220
TABLE 225 SPAIN: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND) 220
TABLE 226 SPAIN: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND) 221
12.3.6 REST OF EUROPE 221
TABLE 227 REST OF EUROPE: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND) 222
TABLE 228 REST OF EUROPE: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND) 222
TABLE 229 REST OF EUROPE: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND) 222
TABLE 230 REST OF EUROPE: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 223
TABLE 231 REST OF EUROPE: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND) 223
TABLE 232 REST OF EUROPE: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND) 224
TABLE 233 REST OF EUROPE: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND) 224
TABLE 234 REST OF EUROPE: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND) 225
12.3.7 EUROPE: RECESSION IMPACT 225

보고서 이미지

※본 조사보고서 [세계의 장기칩 (Organ-on-chip) 시장 (~2029년) : 간, 신장, 장, 폐, 심장] (코드 : BT5883-24) 판매에 관한 면책사항을 반드시 확인하세요.
※본 조사보고서 [세계의 장기칩 (Organ-on-chip) 시장 (~2029년) : 간, 신장, 장, 폐, 심장] 에 대해서 E메일 문의는 여기를 클릭하세요.
*** 아래는 관련 보고서 소개입니다 ***

  • 세계의 치열 교정 용품 시장 (~2027년)
    MD3645-23 / MarketsandMarkets / 2023년 1월 / 마켓츠앤마켓츠 (MarketsandMarkets)는 세계의 치열 교정 용품 시장 규모가 2022년 69억 달러에서 2027년 101억 달러에 이르며, 예측 기간 동안 연평균 7.9%로 성장할 것으로 추정하고 있습니다. 본 조사 리포트는 세계의 치열 교정...“The global orthodontic supplies market size is projected to reach USD 10.1 billion by 2027 from USD 6.9 billion in 2022, at a CAGR of 7.9% during the forecast period.” Worldwide prevalence of malocclusion and increasing patient awareness about the availability of orthodontic treatment in the market are propelling the...
  • 세계의 신약 개발용 인공지능 (AI) 시장 (~2028년) : 제공별, 공정별 (표적 선택, 검증, 리드 생성, 최적화), 약물 설계별 (저분자, 백신, 항체, PK/PD), 건식 실험실별, 습식 실험실별 (단일 세포 분석), 지역별
    HIT7445-23 / MarketsandMarkets / 2023년 11월 / "글로벌 신약 개발용 인공지능 (AI) 시장은 2023년 9억 달러에서 2028년 49억 달러로 예측 기간 동안 연평균 40.2%의 성장률을 기록할 것으로 전망됩니다."AI는 복잡한 생물학적 데이터를 분석하여 잠재적인 신약 개발 타깃을 더...1. 소개 2. 조사 방법 3. 개요 4. 프리미엄 인사이트 5. 시장 개요 6. 산업 동향 7. 세계의 신약 개발용 인공지능 (AI) 시장 규모 : 제공업체별 8. 세계의 신약 개발용 인공지능 (AI) 시장 규모 : 기술별 9. 세계의 신약 개발용 인공지능 (AI) 시장 규모 : 치료 영역별 10. 세계의 신약...
  • 세계의 수술용 흡입 기기 시장 (~2029) : 유형별 (튜브, 팁, 리트랙터, 캐뉼라), 용도별 (일회용, 재사용 가능), 용도별 (일반외과, 신경외과, 정형외과, 심혈관외과, 치과), 최종 용도별
    MD9043 / MarketsandMarkets / 2024년 6월 / ...“글로벌 수술용 흡입 기기 시장은 2024년 3억 7,500만 달러에서 2029년 5억 3,300만 달러로 2024년부터 2029년 사이 6.1%의 연평균 성장률을 기록할 것으로 예상됩니다.”이 시장은 의료 기기의 지속적인 발전으로 인해 성장할 것으로 예상됩니다. 암, 심장병, 비만과 같은 만성 질환은 전 세계적으로 점점 더 흔해지고 있습니다. 이러한 질환은 종종 외과적 개입이 필요하기 때문에...
  • 세계의 항균제 감수성 시험 시장 (~2029년) : 제품별 (수동 (디스크, 스트립, 플레이트), 자동화, 분자), 방법별 (e-test, 디스크 및 한천 확산, 유전자형), 종류별 (항균제, 항진균제), 용도별 (임상, 역학)
    MD 5931 / MarketsandMarkets / 2024년 11월 / ...“세계 항균제 감수성 시험 시장은 2024년 44.5억 달러에서 2029년에는 56.8억 달러에 이를 것으로 예상되며, 예측 기간 중 CAGR은 5.0%로 성장할 것” AST 시장의 주요 이점에는 적절한 동정과 효과적인 항균제 치료의 적시 선택을 통해 환자 치료를 개선하는 데 매우 중요하다는 사실이 포함됩니다. 따라서 AST는 적절한 항균제 사용을 지원하는 올바른 감수성 프로파일을...
  • 세계의 정형외과용 임플란트 시장 (~2029년) : 제품별 (무릎, 고관절, 팔꿈치, 발목, 어깨, 발, 손목), 재료별 (금속 (스테인리스강, 티타늄 합금, 코발트 크롬, 니티놀) 폴리머, 세라믹, 하이브리드), 최종 사용자별 (병원, ASC, 외상)
    MD 9225 / MarketsandMarkets / 2024년 12월 / ...“정형외과용 임플란트의 세계 시장은 2024년 209.4억 달러에서 2029년에는 264.7억 달러에 이를 것으로 예상되며, 2024년부터 2029년까지 연평균 성장률은 4.8%” 다양한 유형의 정형외과용 임플란트에 대한 접근성 증가와 제조 공정에서 3D 프린팅 사용과 같은 기술적 진보가 정형외과용 임플란트 수요를 증가시키고 있습니다. 또한 골절 및 관절 손상을 유발할 수 있는 사고 및 스포츠 부상의...

    • ※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!